COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia

• DOI: 10.1186/s12879-022-07905-2
• Publication Date: 2022-12-06T11:15:18Z
• Authors: Hassan Alwafi; Abdallah Y. Naser; Abdulelah M. Aldh...; Ahmad Alhazmi; Areen Naif Alosaimi; Rasha Abdulaziz M...; Zaid Majeed; Emad Salawati; Rakan Ekram; Mohammed Samannodi; Hamza Assaggaf; Mohammed Almatrafi; Jaber S. Alqahtani; Safaa Mohammed Al...; Faisal Minshawi
• Keywords: Cross-sectional study; Tropical Medicine

Abstract Background Multiple vaccines have been tested in clinical trials for their efficacy and safety. In Saudi Arabia, Pfizer–BioNTech or Moderna were approved children, however, previous studies to report safety profile are limited. This research aims understand the side effect of children's vaccination against SARS-CoV-2 infection Arabia. Methods was an observational retrospective cross-sectional study conducted using online survey Arabia from March May 2022. The inclusion criteria parents aged 18 years above who live vaccinated children. self-reported questionnaire adopted published investigate objectives Descriptive statistics used describe patients’ demographic characteristics, continuous data reported as mean ± S.D., categorical percentages (frequencies), logistic regression identify predictors persistent post-COVID-19 symptoms. Results had a total 4,069 participants. Only 41.9% participants that child(ren) infected with coronavirus. 2.00 median number children (IQR: 1.00–4.00). More than half (64.2%) family member Both received COVID-19 vaccination, according most (88.7%). Most (70.5%) stated all met vaccine. (83.5%) said child two doses vaccine, about (50.4%) those vaccine experiencing effects. addition, majority (78.9%) effects appeared within one day receiving nearly two-thirds (65.7%) lasted between three. A 11,831 cases documented. Pain at injection site, hyperthermia, fatigue effects, accounting 15.3%, 14.1%, 13.2%, respectively. Conclusion It appears minor, tolerable, like described previously trials. Our should encourage public